Wall Street’s top picks for 2026: JPMorgan says a rare biopharma stock could more than triple ⊕
JPMorgan sees shares of Ultragenyx Pharmaceutical soaring more than 200% from current prices.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
JPMorgan
since
auto-detected in 327 stories
38 hours ago
2 days ago
Why Michael Saylor's Strategy could hold the key for the whole bitcoin market ⊖
Strategy can likely avoid forced sales of its bitcoins if its keeps the its enterprise value to cryptocurrency holdings ratio above 1.0, per JPMorgan analysts.
JPMorgan says the time is right to buy this fintech stock that had a poor 2025
JPMorgan's price target implies a 22% upside for shares of Toast from here.
10 days ago
JPMorgan upgrades air filtration stock after $450 million deal announced this week
JPMorgan's updated forecast calls for upside ahead of 25%.
11 days ago
Some of the big risks for the market in 2026, according to JPMorgan
The outlook for 2026 is much murkier for stocks after a strong 2025, according to JPMorgan.
12 days ago
$30 oil? JPMorgan thinks it's possible in a couple of years ⊖
The oil market is facing a big surplus in 2026 and 2027 that will crash oil prices in the absence of production cuts, according to JPMorgan.
JPMorgan upgrades Chinese internet services stock ahead of AI transformation
JPMorgan sees shares rising 69% from here.
22 days ago
Trump calls for probes into Bill Clinton and JPMorgan over ties to Epstein
Investigations come as US president’s own links to the late child sex offender roil his supporters
Trump to ask DOJ to probe Jeffrey Epstein involvement with Clinton, JPMorgan, Summers ⊖
found
President Trump himself is a former longtime friend of sex offender Jeffrey Epstein, who killed himself in a federal jail during Trump's first term.
JPMorgan Chase wins fight with fintech firms over fees to access customer data
The JPMorgan Chase deals mark a shift in the power dynamic between banks, middlemen and the fintech apps that are increasingly threatening incumbents.